SPF 30 Sunscreen is a Topical Spray in the Human Otc Drug category. It is labeled and distributed by Hangzhou Haorun Technology Co.,ltd.. The primary component is Octinoxate; Oxybenzone; Octisalate.
| Product ID | 57817-300_3f1e61d0-49ea-4d8d-ae28-7de4c24ae086 |
| NDC | 57817-300 |
| Product Type | Human Otc Drug |
| Proprietary Name | SPF 30 Sunscreen |
| Generic Name | Octinoxate Oxybenzone Octisalate |
| Dosage Form | Spray |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2013-04-18 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part352 |
| Labeler Name | Hangzhou Haorun Technology CO.,LTD. |
| Substance Name | OCTINOXATE; OXYBENZONE; OCTISALATE |
| Active Ingredient Strength | 6 g/100g; g/100g; g/100g |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2013-04-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | OTC monograph not final |
| Application Number | part352 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2013-04-18 |
| Inactivation Date | 2019-11-27 |
| Ingredient | Strength |
|---|---|
| OCTINOXATE | 6 g/100g |
| SPL SET ID: | 61f3635d-3d95-4387-a48c-45d6c7479857 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 31190-320 | SPF 30 SUNSCREEN | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 31190-330 | SPF 30 SUNSCREEN | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 53942-002 | SPF 30 SUNSCREEN | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE |
| 53942-005 | SPF 30 SUNSCREEN | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE |
| 57817-300 | SPF 30 Sunscreen | OCTINOXATE OXYBENZONE Octisalate |
| 70412-239 | SPF 30 Sunscreen | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 71160-011 | SPF 30 Sunscreen | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 71160-012 | SPF 30 Sunscreen | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 71160-013 | SPF 30 Sunscreen | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 71160-014 | SPF 30 SUNSCREEN | OCTINOXATE, OCTISALATE, OXYBENZONE, TITANIUM DIOXIDE |
| 71585-110 | SPF 30 Sunscreen | ZINC OXIDE |
| 72839-029 | SPF 30 Sunscreen | Avobenzone 3%, Homosalate 8%, Octisalate 5%, Octocrylene 3% |
| 72839-523 | SPF 30 Sunscreen | Avobenzone 3%, Octisalate 5%, Octocrylene 8% |
| 76138-203 | SPF 30 Sunscreen | OCTINOXATE, OXYBENZONE, OCTISALATE |
| 76138-204 | SPF 30 Sunscreen | Octinoxate, Oxybenzone, Octisalate, Titanium Dioxide |
| 79021-010 | SPF 30 Sunscreen | AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE |
| 76150-244 | Big Cloud Defend | SPF 30 Sunscreen |
| 37808-924 | H.E.B ULTRA | SPF 30 Sunscreen |